Loading...
Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication
BACKGROUND: Previous studies have reported that the amplification of some genes, such as Murine Double Minute 2 or 4 and Epidermal Growth Factor Receptor (EGFR), may be related to hyperprogressive disease (HPD). Exploring somatic gene alterations might be an effective method to predict HPD. Herein w...
Na minha lista:
| Udgivet i: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7312344/ https://ncbi.nlm.nih.gov/pubmed/32581041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000793 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|